Increased cdx-2 expression was used as a marker for progression in gastric carcinogenesis [35], while some of the gastric cancers studies showed aberrant expression of cdx-2 in intestinal metaplasia which is a subset of gastric adenocarcinoma [36]. The gene discussed is CDX2; the disease is gastric cancer.